Treatment of congenital adrenal hyperplasia in children aged 0-3 years: A retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.
European journal of endocrinology, vol.187, pp.587-596, 2022 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 187
- Publication Date: 2022
- Doi Number: 10.1530/eje-21-1085
- Journal Name: European journal of endocrinology
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, Aquatic Science & Fisheries Abstracts (ASFA), BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
- Page Numbers: pp.587-596
- Open Archive Collection: AVESIS Open Access Collection
- Istanbul University Affiliated: Yes
Abstract
Objectives: International guidelines recommend additional salt supplementation during infancy in classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The influence of corticoid medication and growth has not been assessed.